29 June 2017 - Martin Shkreli isn't actually on trial for buying an obscure anti-parasitic drug used by AIDS patients and jacking up the price astronomically, but he might as well be.

Three days into Shkreli's trial for alleged securities fraud -- for an issue unrelated to his notorious pharmaceutical price-hike --potential jurors kept circling back to his infamous decision to buy a little-known, little-used drug that was invented before he was born and raise the price overnight, from $13.50 to $750 a pill.

“The only thing I would be impartial about is which prison he goes to," one juror said. That person was dismissed -- as more than 250 were, as my colleague, Renae Merle, reports.

Read Washington Post article